Brian Lenz
2017 - ADMA Biologics
In 2017, Brian Lenz earned a total compensation of $1.1M as Vice President and Chief Financial Officer at ADMA Biologics, a 116% increase compared to previous year.
Compensation breakdown
| Bonus | $158,656 |
|---|---|
| Option Awards | $486,835 |
| Salary | $360,500 |
| Other | $89,965 |
| Total | $1,095,956 |
Lenz received $486.8K in option awards, accounting for 44% of the total pay in 2017.
Lenz also received $158.7K in bonus, $360.5K in salary and $90K in other compensation.
Rankings
In 2017, Brian Lenz's compensation ranked 8,553rd out of 14,666 executives tracked by ExecPay. In other words, Lenz earned more than 41.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,553 out of 14,666 | 42nd |
Division Manufacturing | 3,241 out of 5,770 | 44th |
Major group Chemicals And Allied Products | 1,080 out of 2,074 | 48th |
Industry group Drugs | 854 out of 1,730 | 51st |
Industry Biological Products, Except Diagnostic Substances | 154 out of 316 | 51st |
Source: SEC filing on April 27, 2018.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2017.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019